Cargando…
Modulation of CD19 surface expression in B cell acute lymphoblastic leukemia
Immunotherapeutic targeting of the surface glycoprotein CD19 has markedly improved outcomes in patients with relapsed and refractory B cell progenitor acute lymphoblastic leukemia. Genome-wide CRISPR–Cas9 screening identifies modulators of CD19 mRNA processing that affect the abundance of the surfac...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510525/ https://www.ncbi.nlm.nih.gov/pubmed/36151397 http://dx.doi.org/10.1038/s41590-022-01316-w |
Ejemplares similares
-
Have CD19-directed immunotherapy and haploidentical hematopoietic cell transplantation transformed pediatric B-cell acute lymphoblastic leukemia into a chronic disease?
por: Pariury, Holly, et al.
Publicado: (2021) -
Norovirus Infection in Children with Acute Lymphoblastic Leukemia
por: Reddy, Nalla Anuraag, et al.
Publicado: (2023) -
Glucocorticoid-resistant B cell acute lymphoblastic leukemia displays receptor tyrosine kinase activation
por: Chougule, Rohit A., et al.
Publicado: (2019) -
Investigating CD99 Expression in Leukemia Propagating Cells in Childhood T Cell Acute Lymphoblastic Leukemia
por: Cox, Charlotte V., et al.
Publicado: (2016) -
Impact of CD105 Flow-Cytometric Expression on Childhood B-Acute Lymphoblastic Leukemia
por: Elkholy, Rasha A, et al.
Publicado: (2021)